@ARTICLE{González-González, author = {García-Muñoz, Alejandro and Bologna-Molina, Ronell and Rodríguez, Mario A. and Liceaga-Reyes, Rodrigo and Farfán-Morales, Jose Eduardo and Aranda-Romo, Saray and Molina-Frechero, Nelly and González-González, Rogelio and }, title = {Orosomucoid-1 Expression in Ameloblastoma Variants}, volume = {5}, number = {1}, abstract ={Odontogenic tumors constitute a group of heterogeneous lesions of benign and malignant neoplasms with variable aggressiveness. Ameloblastomas are a group of benign but locally invasive neoplasms that occur in the jaws and are derived from epithelial elements of the tooth-forming apparatus. We previously described orosomucoid-1 protein expression in odontogenic myxomas. However, whether orosomucoid-1 is expressed in other odontogenic tumors remains unknown. Since orosomucoid-1 belongs to a group of acute-phase proteins and has many functions in health and disease, we identified and analyzed orosomucoid-1 expression in ameloblastoma variants and ameloblastic carcinoma using western blot and immunohistochemical techniques. Thirty cases of ameloblastoma were analyzed for orsomucoid-1; five specimens were fresh for western blot study (four benign ameloblastomas and one ameloblastic carcinoma), and 25 cases of benign ameloblastoma for immunohistochemical assays. Orosomucoid-1 was widely expressed in each tumor variant analyzed in this study, and differential orosomucoid-1 expression was observed between benign and malignant tumor. Orosomucoid-1 may play an important role in the behavior of ameloblastomas and influence the biology and development of the variants of this tumor. }, URL = {http://ijmcmed.org/article-1-420-en.html}, eprint = {http://ijmcmed.org/article-1-420-en.pdf}, journal = {International Journal of Molecular and Cellular Medicine}, doi = {10.22088/acadpub.BUMS.5.1.49}, year = {2016} }